ÂÜÀòÂÒÂ×

Eric Pastor has a strong background in the biotechnology and pharmaceutical industry. Eric is currently serving as the SVP of Technology Development and Operations at Spirovant Sciences, Inc. since January 2021. Prior to that, Eric worked as the VP of CMC Operations at Vedere Bio from October 2019 to January 2021. Before joining Vedere Bio, they held various positions at Sanofi, including the Head of Gene Therapy Development from November 2018 to October 2019, and Principal Scientist from April 2011 to November 2018. Eric's earlier experience includes working as a Research Scientist III at AMRI from May 2010 to March 2011, and as the Manager of Analytical Method Development at Targeted Genetics from August 2001 to December 2009.

Eric Pastor has a Bachelor of Science (BSc) degree in Biology/Chemistry from the University of Northern British Columbia (UNBC). The specific timeframe of their education is not provided.